Prior to joining the Albert Einstein College of Medicine as Assistant Professor, JP Maianti co-founded and worked in ExoTherapeutics Inc from inception to stable funding and early drug lead development, a company span off from exosite and substrate-selective inhibition research at Harvard University and the Broad Institute together with Exo co-founders David R. Liu and Alan Saghatelian.
JP holds a Ph.D. in Chemistry and Chemical Biology from Harvard University in 2015 (Liu lab), M.Sc. in Organic Chemistry from the University of Montreal in 2011 (Hanessian lab), and B.Sc. in Biochemistry from the University of Canterbury New Zealand in 2004. For more information, see the Publications & Patents tab.
Media highlights from various career stages